Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 396
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04473781 | Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer | ||
| NCT00091299 | Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors | ||
| NCT00093704 | Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma | ||
| NCT04457232 | Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation | ||
| NCT01525264 | Breast Cancer Screening Intervention | ||
| NCT00646633 | Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors | ||
| NCT02681328 | Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules | ||
| NCT01005472 | Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma | ||
| NCT06650163 | Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors | ||
| NCT04429204 | Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma | ||
| NCT00182637 | Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma | ||
| NCT02888301 | 18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After Interventions | ||
| NCT01180907 | The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases | ||
| NCT00003324 | Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases | ||
| NCT00054574 | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer | ||
| NCT02070406 | Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies | ||
| NCT06810778 | Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) | ||
| NCT03029481 | Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma | ||
| NCT07468916 | Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia | ||
| NCT04280471 | Fecal Microbiota Transplantation for the Treatment of Severe Acute Gut Graft-Versus-Host Disease | ||
| NCT01345136 | Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma | ||
| NCT01859689 | Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer | ||
| NCT04299113 | Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma | ||
| NCT00006968 | Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer | ||
| NCT04279561 | Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate Cancer | ||
| NCT04305925 | Focal Laser Ablation of Prostate Cancer | ||
| NCT06090916 | Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer | ||
| NCT05558904 | An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer | ||
| NCT00344799 | Cytogenetic Study of Ocular Melanoma | ||
| NCT00004880 | Vaccine Therapy in Treating Patients With Advanced Kidney Cancer | ||
| NCT01591577 | Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme | ||
| NCT02597894 | Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy | ||
| NCT00433407 | T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | ||
| NCT03902951 | Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer | ||
| NCT06432036 | Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial | ||
| NCT06448286 | PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma | ||
| NCT01783756 | Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis | ||
| NCT00098462 | Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer | ||
| NCT00005072 | Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer | ||
| NCT02174679 | 68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access) | ||
| NCT00003320 | Radiation Therapy Following Surgery to Remove Brain Metastases | ||
| NCT00070382 | Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer | ||
| NCT04069910 | Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases | ||
| NCT04282824 | Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate Cancer | ||
| NCT07323641 | Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer | ||
| NCT03830918 | Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy | ||
| NCT00004889 | Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia | ||
| NCT02851381 | Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer | ||
| NCT00104767 | Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | ||
| NCT03202472 | Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surgery |
